Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist immune response in tonsillar tissue vs blood
NCT03884296Phase 4Withdrawn
- Sponsor
- Stanford University
- Start
- Apr 2019
- Primary completion
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Stanford University. Planned start Apr 2019; status: withdrawn.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03884296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03884296.